NC-1300-B

CAS No. 104340-52-5

NC-1300-B( —— )

Catalog No. M34341 CAS No. 104340-52-5

NC-1300-B inhibits H(+)-K(+)-ATPase and is used in the study of gastric ulcers.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 411 In Stock
10MG 562 In Stock
25MG 866 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NC-1300-B
  • Note
    Research use only, not for human use.
  • Brief Description
    NC-1300-B inhibits H(+)-K(+)-ATPase and is used in the study of gastric ulcers.
  • Description
    NC-1300-B inhibits H(+)-K(+)-ATPase and is used in the study of gastric ulcers.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    ATPase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    104340-52-5
  • Formula Weight
    313.42
  • Molecular Formula
    C17H19N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(C1=NC=2C=C(C=CC2N1)C)CC=3C=CC=CC3N(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Deslanoside

    Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.

  • PF 03716556

    PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively.

  • 3′,4′,7-Trihydroxyfl...

    7,3',4'-Trihydroxyflavone inhibits osteoclastogenesis via the nuclear factor of activated T cells c1. 7,3',4'-Trihydroxyflavone can markedly inhibit the receptor activator of nuclear factor kappa B ligand-induced osteoclastic differentiation from mouse bone marrow-derived macrophages (BMMs).